Covalent immobilization of stem cell inducing/recruiting factor and heparin on cell-free small-diameter vascular graft for accelerated in situ tissue regeneration
- PMID: 26822178
- DOI: 10.1002/jbm.a.35666
Covalent immobilization of stem cell inducing/recruiting factor and heparin on cell-free small-diameter vascular graft for accelerated in situ tissue regeneration
Abstract
The development of cell-free vascular grafts has tremendous potential for tissue engineering. However, thrombus formation, less-than-ideal cell infiltration, and a lack of growth potential limit the application of electrospun scaffolds for in situ tissue-engineered vasculature. To overcome these challenges, here we present development of an acellular tissue-engineered vessel based on electrospun poly(L-lactide-co-ɛ-caprolactone) scaffolds. Heparin was conjugated to suppress thrombogenic responses, and substance P (SP) was immobilized to recruit host cells. SP was released in a sustained manner from scaffolds and recruited human bone marrow-derived mesenchymal stem cells. The biocompatibility and biological performance of the grafts were evaluated by in vivo experiments involving subcutaneous scaffold implantation in Sprague-Dawley rats (n = 12) for up to 4 weeks. Histological analysis revealed a higher extent of accumulative host cell infiltration, neotissue formation, collagen deposition, and elastin deposition in scaffolds containing either SP or heparin/SP than in the control groups. We also observed the presence of a large number of laminin-positive blood vessels, von Willebrand factor (vWF(+) ) cells, and alpha smooth muscle actin-positive cells in the explants containing SP and heparin/SP. Additionally, SP and heparin/SP grafts showed the existence of CD90(+) and CD105(+) MSCs and induced a large number of M2 macrophages to infiltrate the graft wall compared with that observed with the control group. Our cell-free grafts could enhance vascular regeneration by endogenous cell recruitment and by mediating macrophage polarization into the M2 phenotype, suggesting that these constructs may be a promising cell-free graft candidate and are worthy of further in vivo evaluation. © 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 104A: 1352-1371, 2016.
Keywords: electrospinning; in situ tissue regeneration; neovascularization/angiogenesis; stem cell; vascular graft.
© 2016 Wiley Periodicals, Inc.
Similar articles
-
In Situ Blood Vessel Regeneration Using SP (Substance P) and SDF (Stromal Cell-Derived Factor)-1α Peptide Eluting Vascular Grafts.Arterioscler Thromb Vasc Biol. 2018 Jul;38(7):e117-e134. doi: 10.1161/ATVBAHA.118.310934. Epub 2018 May 31. Arterioscler Thromb Vasc Biol. 2018. PMID: 29853570 Free PMC article.
-
In situ vascular regeneration using substance P-immobilised poly(L-lactide-co-ε-caprolactone) scaffolds: stem cell recruitment, angiogenesis, and tissue regeneration.Eur Cell Mater. 2015 Nov 27;30:282-302. doi: 10.22203/ecm.v030a20. Eur Cell Mater. 2015. PMID: 26614483
-
In situ blood vessel regeneration using neuropeptide substance P-conjugated small-diameter vascular grafts.J Biomed Mater Res B Appl Biomater. 2019 Jul;107(5):1669-1683. doi: 10.1002/jbm.b.34260. Epub 2018 Oct 13. J Biomed Mater Res B Appl Biomater. 2019. PMID: 30315717
-
Quickening: Translational design of resorbable synthetic vascular grafts.Biomaterials. 2018 Aug;173:71-86. doi: 10.1016/j.biomaterials.2018.05.006. Epub 2018 May 5. Biomaterials. 2018. PMID: 29772461 Free PMC article. Review.
-
The role of smooth muscle cells in vessel wall pathophysiology and reconstruction using bioactive synthetic polymers.Physiol Res. 2011;60(3):419-37. doi: 10.33549/physiolres.932038. Epub 2011 Mar 14. Physiol Res. 2011. PMID: 21401306 Review.
Cited by
-
Glycosaminoglycans: From Vascular Physiology to Tissue Engineering Applications.Front Chem. 2021 May 18;9:680836. doi: 10.3389/fchem.2021.680836. eCollection 2021. Front Chem. 2021. PMID: 34084767 Free PMC article. Review.
-
The effect of Substance P/Heparin conjugated PLCL polymer coating of bioinert ePTFE vascular grafts on the recruitment of both ECs and SMCs for accelerated regeneration.Sci Rep. 2019 Nov 19;9(1):17083. doi: 10.1038/s41598-019-53514-6. Sci Rep. 2019. PMID: 31745143 Free PMC article.
-
In Situ Blood Vessel Regeneration Using SP (Substance P) and SDF (Stromal Cell-Derived Factor)-1α Peptide Eluting Vascular Grafts.Arterioscler Thromb Vasc Biol. 2018 Jul;38(7):e117-e134. doi: 10.1161/ATVBAHA.118.310934. Epub 2018 May 31. Arterioscler Thromb Vasc Biol. 2018. PMID: 29853570 Free PMC article.
-
Delivery of Antioxidant and Anti-inflammatory Agents for Tissue Engineered Vascular Grafts.Front Pharmacol. 2017 Sep 21;8:659. doi: 10.3389/fphar.2017.00659. eCollection 2017. Front Pharmacol. 2017. PMID: 29033836 Free PMC article. Review.
-
Promoting Angiogenesis Using Immune Cells for Tissue-Engineered Vascular Grafts.Ann Biomed Eng. 2023 Apr;51(4):660-678. doi: 10.1007/s10439-023-03158-5. Epub 2023 Feb 11. Ann Biomed Eng. 2023. PMID: 36774426 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous